Volume 3, Issue 3, Pages (May 2017)

Slides:

Advertisements

Similar presentations

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) Jeff Donovan, MD, PhD, FRCPC JAAD.

Advertisements

Jeff Donovan, MD, PhD, FRCPC JAAD Case Reports

Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis Franco Rongioletti, MD, Cristina Mugheddu, MD,

Successful treatment of lipoatrophy with normal saline

Marc Mrad, MD, MSc, Nakhle Ayoub, MD, Ribal Mehi, MD JAAD Case Reports

Alopecia after injection of ATX-101 for reduction of submental fat

Volume 2, Issue 6, Pages (November 2016)

Hemorrhagic lesion on the chest wall after trauma

Volume 4, Issue 3, Pages (April 2018)

Volume 3, Issue 3, Pages (May 2017)

An enlarging, ulcerated scalp nodule

Conjunctivitis, mucosal erosions, and moist cutaneous plaques

Localized hypertrichosis after infectious rash in adults

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) Jeff Donovan, MD, PhD, FRCPC JAAD.

Flesh-colored papules and nodules on the face

Treatment of psoriasis vulgaris using low-dose naltrexone

Volume 4, Issue 8, Pages (September 2018)

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Is the hip prosthesis responsible for this rash?

Lip edema Journal of the American Academy of Dermatology

Volume 4, Issue 10, Pages (November 2018)

Pierre-Olivier Grenier, MD, Hélène Veillette, MD, FRCPC

Mark D. Heibel, MD, Haley D. Heibel, MS JAAD Case Reports

Successful treatment of livedoid vasculopathy with rivaroxaban

Dema T. Alniemi, MD, Laura McGevna, MD JAAD Case Reports

Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports

Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC

Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone Natalie Kollman, MD, Jonathan Bass,

Volume 5, Issue 2, Pages (February 2019)

Diffuse pruritic papules

Volume 4, Issue 6, Pages (July 2018)

Pediatric psoriasis treated with apremilast

Successful use of a fractional 2940-nm laser in treating chronic, severe erosive pustular dermatosis of the scalp Hailey E. Grubbs, BS, MS-IV, Chris.

An atypical presentation of a rare disease

Hemorrhagic bullae of the oral mucosa

Julia D. Stiegler, MD, Catherine T. Lucas, MD, Naveed Sami, MD

Spiny keratoderma exposes underlying renal cell carcinoma

Mohammed G. Turkmani, MD, Naief Alnomair, MD JAAD Case Reports

Refractory Sweet's syndrome successfully treated with rituximab

Volume 4, Issue 9, Pages (October 2018)

Slowly progressive chest rash in an elderly woman

Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD

Circinate oral and genital mucositis

Volume 3, Issue 6, Pages (November 2017)

Divalproex sodium: A potential therapy for scleroderma digital ulcers

Papules developing in an old tattoo

Volume 1, Issue 6, Pages (November 2015)

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Fever and indurated subcutaneous plaques

Recalcitrant prurigo nodularis treated successfully with dupilumab

Heidrun Mitzel, MD, Stephan Grabbe, MD, Carmen Loquai, MD

Bilateral sole hyperkeratosis and nonhealing foot mass

Painful violaceus bullae of the hands

Widespread hyperpigmented rash present for 1 year

Treatment of monilethrix with oral minoxidil

Volume 5, Issue 6, Pages (June 2019)

Extensive skin necrosis

Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor Audrey A. Jacobsen, BA, John Strasswimmer,

Multisystemic Langerhans cell histiocytosis in an adult

Erythema multiforme in a child with Kawasaki disease

Lip ulceration in an immunocompromised patient

Figurate erythema for 20 years

Bryan Baillis, MD, John C. Maize, MD JAAD Case Reports

Tattoo pigment removal by halo nevus phenomenon

Morphea in a patient undergoing treatment with ustekinumab

Volume 5, Issue 6, Pages (June 2019)

Brian B. Johnson, MD, Lisa A. Beck, MD, S. Shahzad Mustafa, MD

Alopecia after injection of ATX-101 for reduction of submental fat

Gram-negative folliculitis caused by Morganella morganii

Volume 5, Issue 8, Pages (August 2019)

Presentation transcript:

Volume 3, Issue 3, Pages 215-218 (May 2017) Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab Jennifer A. Baron, MD JAAD Case Reports Volume 3, Issue 3, Pages 215-218 (May 2017) DOI: 10.1016/j.jdcr.2017.02.016 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Affected fingers before treatment with secukinumab. Patient reported severe, disabling pain. JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Affected fingers before treatment with secukinumab. Patient reported severe, disabling pain. JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Labial and gingival mucosa before treatment with secukinumab, showing erosions. Patient reported pain and significant difficulty speaking and eating. JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 4 Erosive circinate glossitis with loss of lingual papillae. JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 5 Labial and gingival mucosa after 1 month of secukinumab treatment initiation (five subcutaneous injections of 300 mg at intervals of 0, 1, 2, 3, and 4 weeks). JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 6 Appearance of tongue after 1 month of secukinumab treatment initiation. JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 7 Affected fingers five days after initial dose of secukinumab (300 mg injected subcutaneously). JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 8 Affected fingers after one month of secukinumab treatment initiation. JAAD Case Reports 2017 3, 215-218DOI: (10.1016/j.jdcr.2017.02.016) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions